-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Medium-chain carboxylic acids, such as n-caproate, are attractive sustainable platform chemicals. However, their microbial production is often limited by electron availability and low product selectivity. This study investigated the effect of hydrogen suppleme…
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Yeast is widely used for recombinant protein production because it supports eukaryotic protein expression and high-cell-density cultivation. Efficient secretion depends on secretion leaders, short N-terminal sequences that direct nascent polypeptides into the …
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Accurate monitoring in complex biofluids remains challenging due to unpredictable skin - electrode interfacial interference and matrix-dependent impedance variations. Here, we present an intelligent enzymatic microneedle platform that achieves calibration-effi…
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Nanomedicine-based cancer immunotherapy integrates nanotechnology with immune modulation, representing a promising strategy to improve both the efficacy and safety of cancer treatment. Despite substantial preclinical potential, clinical translation is hindered…
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
crossref
Andrea C. Fox, John Blazeck
2024-10-25T02:52:33Z
置信度 0.70
-
crossref
Cynthia Ni, Kristala L.J. Prather
2024-01-05T18:14:20Z
置信度 0.70
-
crossref
Axel Theorell, Johann F. Jadebeck, Wolfgang Wiechert, Johnjoe McFadden 等
2024-04-04T08:50:19Z
置信度 0.70
-
crossref
Laura Greenfield, Mariah Brantley, Pauline Geoffroy, Jeffrey Mitchell 等
2024-06-20T03:21:08Z
置信度 0.70
-
crossref
K'yal R. Bannister, Kristala L.J. Prather
2024-09-21T06:28:53Z
置信度 0.70
-
crossref
Xiaolin Liu, Kang Li, Jing Yu, Chuanteng Ma 等
2024-03-11T04:49:48Z
置信度 0.70
-
crossref
Aashutosh Girish Boob, Junyu Chen, Huimin Zhao
2023-11-30T06:57:35Z
置信度 0.70
-
crossref
Xun Jiang, Zhuoxiang Zhang, Xiuming Wu, Changmei Li 等
2024-11-04T08:20:24Z
置信度 0.70
-
crossref
Fengli Wu, Shucai Wang, Dan Zhou, Shukai Gao 等
2024-03-21T23:45:56Z
置信度 0.70
-
crossref
Shane Bassett, Jonathan C. Suganda, Nancy A. Da Silva
2024-11-01T10:50:39Z
置信度 0.70
-
crossref
Helena Schulz-Mirbach, Beau Dronsella, Hai He, Tobias J. Erb
2023-12-29T17:15:09Z
置信度 0.70
-
crossref
Zeinab Rezaei, Amir Soleimani Dinani, Hamid Moghimi
2024-11-28T09:28:50Z
置信度 0.70
-
crossref
Nicole X. Bennis, Jimme Bieseman, Jean-Marc G. Daran
2024-08-10T06:19:16Z
置信度 0.70
-
crossref
Kesi Kurnia, Elena Efimova, Ville Santala, Suvi Santala
2024-11-01T01:12:37Z
置信度 0.70
-
crossref
2024-06-26T14:39:18Z
置信度 0.70
-
crossref
Genlai Dong, Ying Zhao, Wentao Ding, Shijie Xu 等
2024-02-05T07:21:25Z
置信度 0.70
-
crossref
Philippe Vogeleer, Pierre Millard, Ana-Sofia Ortega Arbulú, Katharina Pflüger-Grau 等
2023-11-02T18:14:32Z
置信度 0.70
-
crossref
Yuanke Guo, Rui Zhang, Jing Wang, Ruirui Qin 等
2024-05-15T20:57:26Z
置信度 0.70
-
crossref
Ryosuke Mitsui, Akihiko Kondo, Tomokazu Shirai
2024-08-10T02:44:10Z
置信度 0.70
-
crossref
Mengsu Liu, Junjun Wu, Mingyu Yue, Yang Ning 等
2024-01-13T21:06:20Z
置信度 0.70
-
crossref
Amit Kugler, Karin Stensjö
2024-02-21T12:04:45Z
置信度 0.70
-
crossref
Viswanada R. Bysani, Ayesha S. Alam, Arren Bar-Even, Fabian Machens
2023-11-30T06:57:49Z
置信度 0.70
-
crossref
Yajing Zhang, Tao Sun, Linqi Liu, Xupeng Cao 等
2024-04-15T14:09:07Z
置信度 0.70
-
crossref
Gustav Sjöberg, Alīna Reķēna, Matilda Fornstad, Petri-Jaan Lahtvee 等
2024-02-02T00:56:59Z
置信度 0.70
-
crossref
Behnaz Nowrouzi, Pablo Torres-Montero, Eduard J. Kerkhoven, José L. Martínez 等
2023-11-16T00:59:59Z
置信度 0.70
-
crossref
Shannon R. Pressley, Jake N. Gonzales, Shota Atsumi
2024-09-23T13:09:51Z
置信度 0.70
-
crossref
Oliver Pennington, Sebastián Espinel Ríos, Mauro Torres Sebastian, Alan Dickson 等
2024-10-30T16:09:09Z
置信度 0.70
-
crossref
Nan Lu, Minhua Wei, Xuejing Yang, Yingzi Li 等
2024-10-14T02:26:19Z
置信度 0.70
-
crossref
Eric C. Holmes, Alissa C. Bleem, Christopher W. Johnson, Gregg T. Beckham
2024-10-28T07:36:52Z
置信度 0.70
-
crossref
Xiaolin Liu, Kang Li, Jing Yu, Chuanteng Ma 等
2024-02-20T02:51:56Z
置信度 0.70